Oppenheimer Raises UnitedHealth Group (UNH) Price Target to $295.00

UnitedHealth Group (NYSE:UNH) had its target price raised by Oppenheimer from $276.00 to $295.00 in a research report sent to investors on Wednesday morning, The Fly reports. Oppenheimer currently has an outperform rating on the healthcare conglomerate’s stock. Oppenheimer also issued estimates for UnitedHealth Group’s Q4 2018 earnings at $3.19 EPS, FY2018 earnings at $12.79 EPS, Q1 2019 earnings at $3.41 EPS, Q2 2019 earnings at $3.56 EPS, Q3 2019 earnings at $3.82 EPS, Q4 2019 earnings at $3.70 EPS and FY2019 earnings at $14.49 EPS.

Other analysts have also issued reports about the stock. Morgan Stanley raised their price target on shares of UnitedHealth Group from $277.00 to $278.00 and gave the stock a $255.42 rating in a research report on Wednesday, July 18th. Citigroup raised their price target on shares of UnitedHealth Group from $275.00 to $288.00 and gave the stock a $255.42 rating in a research report on Wednesday, July 18th. Royal Bank of Canada raised their price target on shares of UnitedHealth Group from $282.00 to $284.00 and gave the stock a $255.42 rating in a research report on Wednesday, July 18th. Goldman Sachs Group restated a buy rating and issued a $277.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a hold rating to a buy rating and set a $287.00 price target on the stock in a research report on Sunday, July 15th. One investment analyst has rated the stock with a hold rating, twenty-three have assigned a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group has a consensus rating of Buy and an average price target of $289.41.

NYSE UNH opened at $265.30 on Wednesday. The company has a current ratio of 0.69, a quick ratio of 0.75 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $257.27 billion, a price-to-earnings ratio of 26.35, a P/E/G ratio of 1.58 and a beta of 0.73. UnitedHealth Group has a 52-week low of $203.69 and a 52-week high of $272.81.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.30 by $0.11. The company had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The business’s quarterly revenue was up 12.4% on a year-over-year basis. During the same period last year, the business posted $2.66 EPS. Research analysts forecast that UnitedHealth Group will post 12.81 EPS for the current fiscal year.

In other news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, August 1st. The shares were sold at an average price of $254.79, for a total transaction of $3,821,850.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Steven H. Nelson sold 8,142 shares of UnitedHealth Group stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the sale, the chief executive officer now owns 22,496 shares in the company, valued at $5,961,440. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 94,568 shares of company stock worth $24,950,027. 0.87% of the stock is owned by company insiders.

Institutional investors have recently modified their holdings of the company. White Lighthouse Investment Management Inc. acquired a new position in UnitedHealth Group in the second quarter valued at about $324,000. Wells Fargo & Company MN boosted its position in UnitedHealth Group by 0.5% in the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock valued at $1,887,377,000 after buying an additional 39,480 shares in the last quarter. Wesbanco Bank Inc. boosted its position in UnitedHealth Group by 195.2% in the first quarter. Wesbanco Bank Inc. now owns 76,341 shares of the healthcare conglomerate’s stock valued at $16,337,000 after buying an additional 50,480 shares in the last quarter. Granite Investment Advisors LLC boosted its position in UnitedHealth Group by 1.4% in the second quarter. Granite Investment Advisors LLC now owns 34,225 shares of the healthcare conglomerate’s stock valued at $8,397,000 after buying an additional 476 shares in the last quarter. Finally, M Holdings Securities Inc. boosted its position in UnitedHealth Group by 12.1% in the second quarter. M Holdings Securities Inc. now owns 5,128 shares of the healthcare conglomerate’s stock valued at $1,258,000 after buying an additional 553 shares in the last quarter. Institutional investors and hedge funds own 85.42% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Stock Symbols Definition, Examples, Lookup

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply